Discover novel disease insights and enable Precision Medicine

Taxonomy3® identifies genetically-defined patient subgroups…

…and SNPs associated with disease risk in each of those sub-groups

Following an intriguing study with the Garvan Institute of Medical Research, we have identified the potential for Taxonomy3® analysis to be used for patient stratification in clinical trials, in addition to target identification. We are investigating the potential of this platform to enable future partners to genetically identify patients that are most likely to benefit from the treatment in clinical trials and offering the potential for rescuing of failed clinical trials or for drug repurposing.